SI0763535T1 - Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compounds - Google Patents
Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compoundsInfo
- Publication number
- SI0763535T1 SI0763535T1 SI9630576T SI9630576T SI0763535T1 SI 0763535 T1 SI0763535 T1 SI 0763535T1 SI 9630576 T SI9630576 T SI 9630576T SI 9630576 T SI9630576 T SI 9630576T SI 0763535 T1 SI0763535 T1 SI 0763535T1
- Authority
- SI
- Slovenia
- Prior art keywords
- piperidinylmethyloxazolidin
- derivatives
- preparation
- pharmacological active
- active cns
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19531321A DE19531321A1 (de) | 1995-08-25 | 1995-08-25 | Piperidinylmethyloxazolidinone |
| EP96112990A EP0763535B1 (fr) | 1995-08-25 | 1996-08-13 | Dérivés de pipéridinylméthyloxazolidin-2-one, leur préparation et leur utilisation comme composés pharmacologiques actifs sur le système nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI0763535T1 true SI0763535T1 (en) | 2003-08-31 |
Family
ID=7770390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9630576T SI0763535T1 (en) | 1995-08-25 | 1996-08-13 | Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compounds |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5714502A (fr) |
| EP (1) | EP0763535B1 (fr) |
| JP (1) | JPH09124646A (fr) |
| KR (1) | KR970010766A (fr) |
| CN (1) | CN1067391C (fr) |
| AR (1) | AR004185A1 (fr) |
| AT (1) | ATE228517T1 (fr) |
| AU (1) | AU715310B2 (fr) |
| BR (1) | BR9603509A (fr) |
| CA (1) | CA2184052A1 (fr) |
| CO (1) | CO4750661A1 (fr) |
| CZ (1) | CZ291446B6 (fr) |
| DE (2) | DE19531321A1 (fr) |
| DK (1) | DK0763535T3 (fr) |
| ES (1) | ES2187597T3 (fr) |
| HU (1) | HUP9602324A3 (fr) |
| MX (1) | MX9603567A (fr) |
| NO (1) | NO306993B1 (fr) |
| PL (1) | PL185141B1 (fr) |
| PT (1) | PT763535E (fr) |
| RU (1) | RU2175970C2 (fr) |
| SI (1) | SI0763535T1 (fr) |
| SK (1) | SK281914B6 (fr) |
| TR (1) | TR199600656A2 (fr) |
| TW (1) | TW426680B (fr) |
| UA (1) | UA43860C2 (fr) |
| ZA (1) | ZA967201B (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19739332C1 (de) * | 1997-09-09 | 1998-11-26 | Merck Patent Gmbh | Piperidinylmethyloxazolidinon-Derivat |
| JP2004516295A (ja) * | 2000-12-21 | 2004-06-03 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | サブタイプ選択的なｎ−メチル−ｄ−アスパラギン酸拮抗薬としてのピペリジン誘導体 |
| TW200302095A (en) * | 2002-01-25 | 2003-08-01 | Upjohn Co | Oxazolidinone cotherapy |
| CA2532371C (fr) * | 2003-07-14 | 2012-11-06 | Lg Electronics Inc. | Disque optique a ecriture unique, procede et appareil d'enregistrement d'informations de gestion sur un disque optique a lecture unique |
| GB201317609D0 (en) | 2013-10-04 | 2013-11-20 | Cancer Rec Tech Ltd | Inhibitor compounds |
| GB201505658D0 (en) | 2015-04-01 | 2015-05-13 | Cancer Rec Tech Ltd | Inhibitor compounds |
| GB201617103D0 (en) | 2016-10-07 | 2016-11-23 | Cancer Research Technology Limited | Compound |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0713017B2 (ja) * | 1986-06-18 | 1995-02-15 | 日本ケミファ株式会社 | 脳細胞保護作用を有する医薬組成物 |
| DE3723797A1 (de) * | 1987-07-18 | 1989-01-26 | Merck Patent Gmbh | Oxazolidinone |
| DE4005371A1 (de) * | 1990-02-21 | 1991-08-22 | Merck Patent Gmbh | Oxazolidinone |
| DE4017211A1 (de) * | 1990-05-29 | 1991-12-05 | Merck Patent Gmbh | Oxazolidinone |
| DE4324393A1 (de) * | 1993-07-21 | 1995-01-26 | Merck Patent Gmbh | 4-Aryloxy- und 4-Arylthiopiperidinderivate |
-
1995
- 1995-08-25 DE DE19531321A patent/DE19531321A1/de not_active Withdrawn
-
1996
- 1996-07-19 TW TW085108824A patent/TW426680B/zh not_active IP Right Cessation
- 1996-08-07 CZ CZ19962338A patent/CZ291446B6/cs not_active IP Right Cessation
- 1996-08-09 TR TR96/00656A patent/TR199600656A2/xx unknown
- 1996-08-13 EP EP96112990A patent/EP0763535B1/fr not_active Expired - Lifetime
- 1996-08-13 PT PT96112990T patent/PT763535E/pt unknown
- 1996-08-13 DK DK96112990T patent/DK0763535T3/da active
- 1996-08-13 ES ES96112990T patent/ES2187597T3/es not_active Expired - Lifetime
- 1996-08-13 DE DE59609913T patent/DE59609913D1/de not_active Expired - Fee Related
- 1996-08-13 AT AT96112990T patent/ATE228517T1/de not_active IP Right Cessation
- 1996-08-13 SI SI9630576T patent/SI0763535T1/xx unknown
- 1996-08-14 SK SK1061-96A patent/SK281914B6/sk unknown
- 1996-08-19 AU AU62151/96A patent/AU715310B2/en not_active Ceased
- 1996-08-21 JP JP8218981A patent/JPH09124646A/ja not_active Withdrawn
- 1996-08-21 CN CN96111145A patent/CN1067391C/zh not_active Expired - Fee Related
- 1996-08-21 UA UA96083319A patent/UA43860C2/uk unknown
- 1996-08-22 MX MX9603567A patent/MX9603567A/es not_active IP Right Cessation
- 1996-08-22 BR BR9603509A patent/BR9603509A/pt active Search and Examination
- 1996-08-23 AR ARP960104090A patent/AR004185A1/es unknown
- 1996-08-23 NO NO963524A patent/NO306993B1/no unknown
- 1996-08-23 CO CO96044887A patent/CO4750661A1/es unknown
- 1996-08-23 RU RU96117005/04A patent/RU2175970C2/ru not_active IP Right Cessation
- 1996-08-23 PL PL96315801A patent/PL185141B1/pl unknown
- 1996-08-23 KR KR1019960035108A patent/KR970010766A/ko not_active Application Discontinuation
- 1996-08-23 HU HU9602324A patent/HUP9602324A3/hu unknown
- 1996-08-23 US US08/701,852 patent/US5714502A/en not_active Expired - Fee Related
- 1996-08-23 CA CA002184052A patent/CA2184052A1/fr not_active Abandoned
- 1996-08-23 ZA ZA967201A patent/ZA967201B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL326353A1 (en) | Pharmaceutically active quinozolinic compounds | |
| GB9526511D0 (en) | Pharmaceutically active compounds | |
| SI0763535T1 (en) | Piperidinylmethyloxazolidin-2-one derivatives, their preparation and their use as pharmacological active CNS compounds | |
| HUP9600665A2 (en) | Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation | |
| HUP0004734A3 (en) | Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors | |
| GB9510468D0 (en) | Pharmaceutically active compounds | |
| GB9515884D0 (en) | Pharmaceutically active compounds | |
| GB9501122D0 (en) | Pharmaceutically active compounds | |
| GB9502229D0 (en) | Pharmaceutically active compounds | |
| GB9502429D0 (en) | Pharmaceutically active compounds | |
| GB9502541D0 (en) | Pharmaceutically active compounds | |
| GB9502668D0 (en) | Pharmaceutically active compounds | |
| GB9502669D0 (en) | Pharmaceutically active compounds | |
| GB9502670D0 (en) | Pharmaceutically active compounds | |
| GB9505076D0 (en) | Pharmaceutically active compounds | |
| GB9505677D0 (en) | Pharmaceutically active compounds | |
| GB9506274D0 (en) | Pharmaceutically active compounds | |
| GB9507641D0 (en) | Pharmaceutically active compounds | |
| GB9509942D0 (en) | Pharmaceutically active compounds | |
| GB9510406D0 (en) | Pharmaceutically active compounds | |
| GB9510461D0 (en) | Pharmaceutically active compounds | |
| GB9500099D0 (en) | Pharmaceutically active compounds | |
| GB9513686D0 (en) | Pharmaceutically active compounds | |
| GB9513745D0 (en) | Pharmaceutically active compounds | |
| GB9513775D0 (en) | Pharmaceutically active compounds |